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The activity of acid a-glucosidase in cultured fibroblasts from adult patients with the lysosomal storage 
disease glycogenosis type II is only 10% of normal. A normal activity per molecule is found for the mature 
as well as for the precursor form of acid a-glucosidase in adult mutant fibroblasts. Excessive lysosomal 
breakdown of mature nzyme purified from mutant fibroblasts and taken up by acceptor cells does not 
occur. However, the NH4Cl-stimulated secretion of a precursor form of acid a-glucosidase by adult 
mutant fibroblasts is markedly reduced. The results are indicative of a defect during the production of acid 
a-glucosidase. 
Glycogenosis type H Pompe disease a-Glucosidase Synthesis 
(Human skin fibroblast) 
Processing 
1. INTRODUCTION 
Glycogenosis type II is an autosomal recessive 
glycogen storage disease, in which deficiency of 
lysosomal (acid) a-glucosidase (EC 3.2.1.20) is the 
basic defect [1]. The amount of acid a-glucosidase 
present in cultured fibroblasts [2] and urine [3] 
from patients with adult forms of the disease is 
reduced to 10% of normal. Since no kinetic, physi- 
cal nor immunological parameters of the adult 
mutant a-glucosidase were found to be abnormal 
[2,3], it was hypothesized that the enzyme was 
either synthesized at reduced rate or degraded at 
increased rate [2]. 
Here, we show that not only the cellular but also 
the extracellular precursor form of acid a- 
glucosidase from adult mutant fibroblasts has a 
normal stability and normal specific catalytic ac- 
tivity. Moreover, the apparent biological half-lives 
of acid a-glucosidase from adult mutant and con- 
trol fibroblasts are comparable. The only striking 
difference between control and mutant fibroblasts 
is, that the amount of precursor acid a-glucosidase, 
measured as NH4Cl-stimulated enzyme secretion, 
is markedly reduced in mutant cells. We conclude 
that the defect in adult forms of glycogenosis type 
II lies in an early step in the realization process of 
acid a-glucosidase. 
2. MATERIALS AND METHODS 
2.1. Secretion and uptake of enzyme in cell culture 
Human skin fibroblasts were cultured in Ham's 
FI0 medium supplemented with 10% fetal calf 
serum and antibiotics. For enzyme secretion stud- 
ies, the cells were seeded in 24-well tissue culture 
plates and 48 h later, when the cultures had 
reached confluence, the medium was replaced by 
500 #1 fresh medium with added to it 5% inacti- 
vated (4h, 37°C pH 10) fetal calf serum and 
NH4C1 at 10 mM final conc. At given time points a 
75/~1 aliquot was taken and lysosomal enzyme ac- 
tivities were measured as follows: acid a- 
glucosidase; 50/~1 medium + 100 t~l 4-methv1- 
umbelliferyl-a-D-glucopyranoside, fl-galactosi- 
dase; 10/d ,medium + 20/~1 4-methylumbelli- 
feryl-fl-D-galactopyranoside, and fl-N-acetylhexo- 
saminidase; 5/d + 20/zl 4-methylumbelliferyl-fl- 
D-glucosaminide. Substrate concentrations were as 
in [4], and incubation times were 2 h, 1.5 h and 
0.5 h, respectively, for the different enzymes. Reac- 
tions were stopped with 500 ~tl sodium carbonate 
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buffer (0.5 M) pH 10.7. Enzyme uptake and sta- 
bility studies were also carried out in 24-well cul- 
ture plates. 5-15 Units of acid a-glucosidase, pu- 
rified from control cells or fibroblasts from pa- 
tients with adult forms of glycogenosis type II (as 
in [5]) were added overnight to the medium 
(500 t~l) of acceptor cells. For this purpose we used 
fibroblasts from patients with the infantile form of 
glycogenosis type II, without any detectable acid 
a-glucosidase activity. 1 Unit hydrolyzes 1nmol 4- 
methylumbelliferyl-c~-glucopyranoside/h. 
t , -  
2.2. Immunotitration 
Intracellular enzyme was purified from mass 
cultures of control or mutant fibroblasts. Extra- 
cellular (precursor) enzyme was obtained by stim- 
ulating fibroblasts for 2 days with 10 mM NH4C1 
to secrete newly synthesized lysosomal enzymes. In 
the latter case, 6 × 106 control cells or 60 × 106 
mutant cells were maintained in medium with 1% 
inactivated fetal calf serum. The medium was 10- 
50-times concentrated and used as such. Cellular 
and medium enzyme was used in a concentration 
of 1-4 units/10/~l. Samples of 10~1 were incu- 
bated overnight at 4°C with 10 ~tl serially diluted 
antiserum, raised in rabbits against highly purified 
placental acid a-glucosidase. Subsequently, 50 ~tl 
substrate solution was added containing 50 mg 
glycogen/ml in 0.2M sodium acetate buffer 
(pH4.3). The samples were incubated for l h at 
37°C and the reaction was terminated by heating 
for 1 min at 100°C. The amount of glucose formed 
in the reaction was measured by adding 200/xl 
glucose reagent, as in [2]. 
3. RESULTS AND DISCUSSION 
In the first series of experiments, acid c~- 
glucosidase was purified from mass cultures of 
control fibroblasts and fibroblasts from adult pa- 
tients, in order to compare the specific catalytic 
activities of the normal and mutant enzymes. The 
assay is based on the fact that acid a-glucosidase 
bound to antibody molecules loses its activity for 
the natural substrate glycogen. This feature results 
in an inverse linear relation between the activity of 
acid a-glucosidase and the amount of antiserum 
added to the reaction mixture (fig.l). As shown, 
parallel ines are found in all instances comparing 
the normal and mutant enzymes. Thus, equal 
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Fig.1. Immunotitration f normal and mutant a-glucosi- 
dase: (- - -) acid a-glucosidase purified from fibroblasts; 
( - - )  acid a-glucosidase in concentrated medium; 
( , - - , )  adult mutant (177LAD); (o o) adult mutant 
(338 LAD); (. .) control (261 LAD); (x - -x )  
control (GRA). 
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Fig.2. In viva stability of endocytosed acid ~-glucosi- 
dase. Addition of normal or adult mutant acid a-glucosi- 
dase over 16 h resulted in an intracellular activity of 2-  
10 units/mg cellular protein. The initial activity after 
16 h uptake was set at 100%. Results are shown for acid 
a-glucosidase purified from: A, control cells (26 i LAD); 
B, adult patient ceils (177LAD); C, control cells (GRA); 
D, adult patient cells (338LAD). 
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amounts of antibody are needed to inactivate a 
fixed amount of both normal enzyme and enzyme 
from mutant cells. The conclusion, therefore, is 
that the catalytic activity of the mutant enzyme per 
enzyme molecule is indentical to that of normal 
acid a-glucosidase. 
In the second set of experiments, the purified 
normal and adult mutant enzymes were added to 
the culture medium above fibroblasts from a pa- 
tient with infantile glycogenosis type II, which are 
fully deficient in acid a-glucosidase. The aim was 
to test the intralysosomal stability of the normal 
and the adult mutant enzymes after endocytosis by 
the acceptor cells. Results of these experiments are 
illustrated in fig.2. Over 16 h, 1-5% of the added 
enzyme, purified from control fibroblasts or cells 
from adult patients, is internalized and recovered 
as active enzyme in the acceptor cells. The uptake 
efficiency is the same for normal and mutant en- 
zymes (not shown). Fig.2 illustrates that there is a 
gradual decline of intracellular activity over a 
period of 10 days following uptake. The estimated 
half-life is 5 -7  days for the normal enzyme as well 
as for the adult mutant acid a-glucosidase. 
From this observation it can be concluded that 
the 90% reduction of acid a-glucosidase activity in 
fibroblasts from patients with the adult form of 
glycogenosis type II is not caused by an increased 
susceptibility of a mutant enzyme to intralysoso- 
mal degradation. Moreover, when purified normal 
acid a-glucosidase was administered to fibroblasts 
from adult patients, a normal uptake and intra- 
cellular stability was observed. This excludes that 
in the adult form of glycogenosis type II, degrada- 
tion of what appears to be a normal enzyme is 
promoted by lack of protection against lysosomal 
proteases. Such a genetically determined lack of 
protection has been described for fl-galactosidase 
in certain patients with a combined deficiency of 
neuraminidase and fl-galactosidase [6,7]. 
Since lysosomal enzymes undergo, during their 
synthesis, a series of post-translational modifica- 
tions involving glycosylation and size reductions 
[8-10], in vivo measurement of enzyme synthesis 
will give the net result of some or all of these steps 
in enzyme realization. It has been shown, however, 
that transport of newly formed lysosomal enzymes 
to the lysosomes can be blocked by adding NH4CI 
to the culture medium of fibroblast, whereby 85-  
90% of newly synthesized high M r precursor en- 
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Fig.3. NH4Cl-stimulated secretion of a-glucosidase and 
fl-hexosaminidase. At intervals of 4, 16, 24, 40 and 48 h 
after addition of NH4C1 the activities of a-glucosidase 
and fl-hexosaminidase in the medium were measured. 
The activity of a-glucosidase is expressed in nmoi. 
h- i .mg protein-i, that of fl-hexosaminidase in
/tmol. h -l . mg protein:-I: ( - - )  acid a-glucosidase; (- - 
-) fl-hexosaminidase; (o - - , )  control cells (GRA); 
(x - -x ' )  cells from an adult patient (338LAD). 
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Fig.4. Secretion of acid a-glucosidase. At intervals of 16, 
24, 40 and 48 h after addition of NHaCI, medium sam- 
ples were taken and the lysosomal enzyme activity ratios 
for each individual cell line were plotted: C, 6 different 
control cell lines; A, 3 different cell lines from adult 
patients (196LAD, 338LAD, 177LAD); I, 2 cell lines 
from patients with the infantile form of glycogenosis II 
(266LAD, 217LAD). 
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zymes are secreted [11,12]. Such intervention i the 
normal processing pathway of lysosomal enzymes 
allows us to discriminate between defects in early 
or late steps in the realization process. 
As early as 4 h after the addition of NH4C1, the 
secretion of catalytically active acid a-glucosidase 
can be measured in the medium. The accumula- 
tion of enzyme proceeds almost linearly for up to 2 
days (fig.3). This figure also shows that the secre- 
tion of acid a-glucosidase by adult mutant fibro- 
blasts is much reduced, whereas the mutant ceils 
secrete similar amounts of/3-hexosaminidase com- 
pared to control cells. 
Although lesser in amount, the specific catalytic 
activity of acid a-glucosidase secreted by adult mu-' 
tant fibroblasts was the same as that of the enzyme 
secreted by normal cells (fig.l). Moreover, these 
precursor enzymes from control and mutant cells 
were equally stable and they lost < 10% of activity 
over 52 h in 37°C culture medium. The data from 
several series of experiments, with different cell 
lines, are summarized in fig.4. The secretion of 
acid a-glucosidase is presented as the ratio of acid 
a-glucosidase to /3-galactosidase and to /3-hex- 
osaminidase, to reduce the effect of biological vari- 
ation. The mean ratio of a-glucosidase to /3-hex- 
osaminidase is 5 × 10-3 for control cell lines and 
0.4 × 10 -3 for cell lines from adult patients. The 
ratio of a-glucosidase to/3-galactosidase i  0.5 for 
control vs 0.06 for mutant cells. On the average, 
fibroblasts from adult glycogenosis II patients e- 
crete only 8-12% of the normal amount of precur- 
sor acid a-glucosidase. Fibroblasts from patients 
with the infantile form of this disease do not se- 
crete any active acid a-glucosidase. 
On the basis of the combined observations we 
conclude that the mutation in adult forms of 
glycogenosis type II results in a diminished net 
production of a precursor form of acid a-glucosi- 
dase. 
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